HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Digital Sales Hot But Shareholders Slow To Warm To China Expansion Deal

This article was originally published in The Rose Sheet

Executive Summary

GNC’s Amazon storefront has an impact as the store and the firm’s website combine for 27% online sales growth in the first quarter. The firm delays a vote on a planned deal that would makes Harbin Pharmaceutical its largest shareholder, with a board voting bloc of five seats, and would launch a JV by the firms to expand GNC's presence in China.

You may also be interested in...



GNC In Rough Seas From COVID-19 Pandemic; Vitamin Shoppe Safe In Port Under New Owner

GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.

GNC Results Slumped, And Then Coronavirus Pandemic Spread Uncertainty Across 2020

Refinancing its debt and reducing its network of stores also expected as drags on 2020 earnings, GNC says. No avoiding the coronavirus pandemic, though, during its earnings briefing; with uncertainty brought on by the pandemic added to other headwinds, it didn’t offer guidance on its 2020 results.

GNC Links Pipeline To Loyalty Program Trends, Builds Private Label Lines

CEO Ken Martindale says research and development linked to firm’s loyalty program, which provides data on the needs of the nearly 15m customers enrolled. “The data-driven insight we gain from our loyalty program are beginning to help us shape our product development and innovation,” he says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS121589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel